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This project addresses the possible role of mitochondrial estrogen metabolism and its inhibition in mammary carcinogenesis of female ACI rats. Diethylstilbestrol (DES) have been shown to cause cancer in several animals species whereas diallyl sulfide (DAS) inhibits cancer.
We hypothesis that DES is metabolized by the mitochondria to reactive metabolites producing DNA adducts.
We further propose that DAS will prevent this metabolism thus prevent the production of DNA adducts. The results of this study demonstrates that organelles (mitochondria, microsomes, and nuclei) catalyze the oxidation and reduction of DES and diallyl sulfide inhibits this metabolism in a noncompetitive fashion.
Furthermore, DAS inhibits the formation of mitochondrial DNA adducts in both in vitro and in vivo. The results of this study will help elucidate the mechanism of estrogen induced breast cancer. This data will provide a foundation for the further investigation of the chemopreventive properties of DAS and structurally similar compounds. 14 
INTRODUCTION
This project addresses the role of mitochondrial estrogen metabolism and the inhibition of estrogen metabolism in mammary carcinogenesis. Female ACI rats serves as our animal model and Diethylstilbestrol (DES) as our model estrogen. Diallyl sulfide, a component of garlic which has been shown to inhibit the induction of cancer in several animal species (Wargovich, 1987; Wargovich et.al., 1988; Wattenburg et.al., 1989; Sparnins et.al., 1988; & Hays et.al., 1987) , was tested for its ability to prevent DES metabolism. We have investigated the capabilities of the various subcellular fractions (microsomes, mitochondria, and nuclei) to metabolize DES and the ability of DAS to inhibit this metabolism. We have also investigated the ability of DES to produce DNA adducts in mitochondrial DNA and the ability of diallyl sulfide to inhibit adduct formation in vitro as well as in vivo. The findings of this study will provide us with a rationale to develop diallyl sulfide and structurally related compounds as chemopreventive agents.
BODY
We propose that diethylstilbestrol (DES) enters into redox reactions in the presence of mitochondrial enzymes. The reactive species generated during redox-cycling of DES are postulated to bind to mitochondrial DNA which may cause mitochondrial genetic instability. This genetic instability is proposed to play an important role in the induction of breast cancer. We further propose that diallyl sulfide will inhibit the redox-cycling of DES. This inhibition may lead to the inhibition of estrogen-induced carcinogenesis. To test this hypothesis we have identified the following specific aims: 5. The oxidation products will be analyzed by UV absorption and HPLC analysis. 6. In vitro reduction reactions will be conducted with DES quinone, NADH (reduction cofactor), and individual organells. 7. The reduction products will be analyzed by UV absorption and HPLC analysis. 8. In parallel experiments various concentrations of DAS will be added to determine its inhibitory effects on DES metabolism.
Progress for Task 1 Animal and chemical model:
Female ACI rats was used to study the mechanism of estrogen-induced breast cancer. It has been demonstrated that estrogen produce breast cancer in ACI rats (Shull et.al., 1997) . The administration of DES during pregnancy increases the risk of developing breast and endometrial cancer in humans and animals (Colton et. at., 1993) .
Specific Aim 1 & 2: Redox cycling of DES and its inhibition by DAS.
Female ACI rats (10) were treated for four days with a daily dose of beta napthoflavone (50 mg/kg i.p.) to induce cytochrome p-450. The rats were sacrificed by carbon dioxide exposure. The breast tissue was be removed, weighed, and homogenized in 1:10 wt/vol (0.25 M sucrose, 1.0 mM EDTA, 2.5 uM PMSF). Microsomes, mitochondria, and nuclei from the breast tissue were isolated by differential centrifugation. The mitochondria were treated with a 1.6% digitonin solution and centrifuged to collect pure mitoplast (mitochondria without outer membrane). The removal of the outer membrane of the mitochondria makes the enzymes more accessible to the substrate and reduces the chances of cytosolic contamination. The organelles were used to catalyze the oxidation and reduction of DES. The oxidation and reduction products generated by the organelles were analyzed by UV absorption and HPLC analysis.
Determination of the purity of mitoplasts:
The purity of mitoplasts was assessed by both morphological and biochemical analyses. Mitoplasts were stained with eosin and hematoxylin. Phase contrast microscopy did not reveal any cellular contamination. The determination of cytochrome C oxidase (Whorton & Tzagoloff, 1967) , an enzymatic marker of mitochondria, showed 120-125 jtmol/mg protein/min specific activity. Microsomal contamination was assessed by measuring the activity of glucose 6phosphatase, an enzymatic marker of endoplasmic reticulum (Baginski et.al., 1974) . The activity of glucose 6-phosphatase in mitoplasts was less than 1% of that found in microsomes (5.0 pmol/mg protein/min in mitoplasts vs 735 pmol/mg protein/min in microsomes). This is in agreement with the report ofNiranjan et.al. (1980 & 85) .
Determination of the purity of microsomes:
The purity of microsomes was assessed by both morphological and biochemical analyses. Microsomal prepairations were stained with eosin and hematoxylin. Phase contrast microscopy did not reveal any nuclear contamination.
Mitochondrial contamination was assessed by measuring the cytochrome C oxidase activity oxidase (Whorton & Tzagoloff, 1967) . There was less than 2 % microsomal contamination. Bases on enzyme analysis.
Determination of the purity of nuclei:
The purity of the nuclei was assessed by morphological and biochemical analyses. We stained the nuclei preparations with eosin and hematoxylin. Phase contrast microscopy revealed the presence of intact nuclei. There was little cytochrome C oxidase and glucose 6-phosphatase activity which indicated that the nuclei prepairations were pure.
Oxidation reaction system:
The reaction conditions consists of 10mM phosphate buffer, pH 7.5, 120pLM cumene hydroperoxide, 420 ýtg/ml mitoplasts and 346 ptg/ml of microsomes in a final volume of 1.0 ml. Various concentrations (0-120M) of DES was used to determine the kinetics constants of the reactions. For specific aim 2 various concentrations of DAS (186 pLM and 373 pM) was added to test the inhibition of DAS on the oxidation of DES.
No cumene hydroperoxide (oxidation cofactor) will be used in control reactions.
Reduction Reaction System:
The reaction conditions consists of 10mM phosphate buffer, pH 7.5, 50 pIM NADPH, 420[tg/ml mitoplasts and 346 [tg/ml of microsomes in a final volume of 1.0 ml. Various concentrations (0-60QM) of DES quinone was used to determine the kinetics constants of the reactions. For specific aim 2 various concentrations of DAS ( 186 pM and 373 [M) was added to test the inhibition of DAS on the reduction of DES quinone.
No NADPH (reduction cofactor) will be used in control reactions HPLC analysis:
The oxidation and reduction products from similar reactions as previously described were extracted with water saturated ethyl ether. The reaction mixture was dried under nitrogen and metabolites were reconstituted in methanol. An appropriate amount(10-50ul) of sample was injected into the HPLC. A methanol/water gradient consisting of 36% to 83% methanol was run using a C 14 reverse phase column from 0 to 30 minutes at a flow rate of 1 ml/min. The U.V. detection was performed at a wavelength of 254nm.
Results for Task 1: Oxidation of DES:
Mitoplasts were incubated in the presence of DES and cumene hydroperoxide. DES quinone was detected by U.V. spectroscopy. The UV spectral analysis of the mitochondrial mixture containing DES and cumene hydroperoxide revealed a gradual increase in the absorbance at 312 nm. The spectral pattern was identical to that of synthetic DES quinone ( Fig  1) . In the control reactions no DES quinone was produced. In oxidation reactions that contained DAS (373tM) the production of DES quinone was reduced by 50%. The rate of DES quinone formation in the presence of mitoplasts and cumene hydroperoxide was dependent on the concentration of DES (Fig. 2) . A Lineweaver-Burk plot of rate of formation of DES quinone at various concentrations of DES yielded a Km of 35.7 ýtM and Vmax of 3.45 nmol/mg protein/min.).
The kinetic constants of the reactions were determined by using various concentrations of DES (0-120M) and two concentrations of DAS ( 186 tM and 373 piM) With increasing concentrations of DAS the Km remained constant whereas the Vmax decreased (3.45, 2.44, and 1.82 nmol/mg protein/min. respectively. This data indicates that the mitochondria is capable of metabolizing DES to DES quinone and DAS is capable of inhibiting this metabolism. Based on the kinetic constants the nature of this inhibition seems to be noncompetitive. Results from the oxidation in microsomal reactions were similar to those in mitochondria. i.e. The microsomes were capable of oxidizing DES to DES quinone and DAS inhibited this oxidation (Data not shown).
Reduction of DES quinone:
Mitoplasts were incubated in the presence of DES quinone and NADH. The disappearance of DES quinone was detected by UV spectroscopy. The UV spectral analysis of the mitochondrial mixture containing DES quinone and NADH revealed a gradual decrease in the absorbence at 312 nm (Fig 3) . In the control reactions little DES quinone was reduced. In the reduction reactions that contained DAS (373iM) the amount of DES quinone reduced was decreased by 50%. The rate of DES quinone disappearance in the presence of mitoplasts and NADH was dependent on the concentration of DES quinone (Fig. 4) . A Lineweaver-Burk plot of rate of disappearmce of DES quinone at various concentrations of DES yielded a Km of 50.0 [tM and Vmax of 2.0 nmol/mg protein/min. The kinetic constants of the reactions were determined by using various concentrations of DES Quinone (0-60 jM) and two concentrations of DAS ( 186 jM and 373 jiM). With increasing concentrations of DAS the Km remained constant whereas the Vmax decreased (2.0, 1.5, and 1.25 nmol/mg protein/min. respectively). This data indicates that the mitochondria is capable of reducing DES Quinone to DES and DAS is capable of inhibiting this reduction. Based on the kinetic constants, the nature of this inhibition seems to be noncompetitive. Results from the reduction in microsomal reactions were similar to those in the mitochondria. ie The microsomes were capable of reducing DES quinone to DES and DAS inhibited this reduction (Data not shown).
The kinetic constants for the mitochondrial and microsomal oxidation and reduction reactions are summarized in Table 1 . The kinetic constants were not determined for nuclear oxidation and reduction reactions due to the small amount of nuclei that could be isolated from the breast tissue.
HPLC Analysis:
Oxidation and reduction reactions for all three cellular subfractions (mitochondrial, microsomal, and nuclear) were confirmed by HPLC analysis (Table 2 ). HPLC analysis revealed that DAS inhibited the oxidation of DES in a dose dependent manner in the mitochondria, microsomes, and nuclei. Similar results were seen in reduction reactions ( Table 3) .
Statement of Work (Task 2):
To demonstrate the in vitro production of DNA adducts by DES metabolites and the inhibition of adduct formation by DAS.
1. Organelles (mitoplasts, nuclei, and microsomes) will be isolated by differential centrifugation. 2. Ten rats will be needed to isolate adequate amount of organelle form breast tissue. 3. The rats will be dosed with beta naphthoflavone to induce cytochrome p-450s that metabolize estrogen and sacrificed via carbon dioxide exposure.
4.
In vitro oxidation reactions will be conducted with DES, cumen hydroperoxide (oxidation cofactor), individual organells, and DNA to determine the adduct forming potential of DES metabolites. 5. The DNA will be extracted and analyzed for adducts by 32 P-Postlabeling. 6. Parallel experiments will be conducted with the addition of Diallyl sulfide to oxidation reaction mixtures to determine if DAS will inhibit the formation of DNA adducts generated by the metabolism of DES.
Progress for Task 2
In vitro: Mitoplast, microsomes, and nuclei were prepared as described previously. DNA (200[tg) was added to the oxidation system as described previously to assess the genotoxicity of DES metabolites (DES quinone) and DAS (100uM) will be added to reaction system to determine if DAS will inhibit the formation of DES quinone adducts.
DNA Isolation:
The mitochondria and nuclei will be isolated by differential centrifugation. The DNA was isolated from purified mitoplast and nuclei. Pure mitoplast and nuclei was suspended in 50 mM Tris, 10 mM EDTA, pH 8.0 containing 1% SDS. After five minutes of gentle shaking, samples are to be treated with RNAase-A (150 ug/ml) and RNAase TI (20 U/ml) for 30 minutes and incubated with proteinase k (500 ug/ml) for 1 hr at 37°C. The DNA will be extracted once with phenol:chloroform:isoamyl alcohol (25:24:1) and three times with chloroform:isoamyl alcohol (24:1). Two volumes of ice-cold ethanol will be added in aqueous extract, chilled at -80'c for 15 minutes and centrifuged at 11,000 x g. The purity of DNA will be checked by ultraviolet spectroscopy and agarose gel electrophoresis.
P-Post Labeling:
Analysis of covalent modification in DNA will be carried out by the 32 p-post labeling technique (Reddy & Randerath, 1989) . DNA (10 ug) will be digested with micrococcal nuclease, spleen phosphodiesterase, and nuclease P1 as described previously (Gupta et al., 1982; and Reddy & Randerath, 1989) . Enzymatic reactions and AT-32 P will be used to label the digested nucleotides. The unmodified nucleotides will be separated from the adducts on polyetheleneimine(PEI)-cellulose TLC plates using DI, 2.3 M sodium phosphate, pH 5.7. The resolution of 32 p-post labeled adducts will be carried out on polyetheleneimine(PEI)-cellulose TLC plates with D3, 4.2 M lithium formate and 6.8 M urea, pH 3.3; D4, 0.8 M sodium phosphate, 0.5 M Tris and 8.5 M urea, pH 8.2; and D5, 1.7 M phosphate, pH 6.0. The 32 p_ labeled adduct spots will be detected by autoradiography using Kodak X-Omat film. The spots containing 32 p-post labeled adducts will be excised from TLC plates, and levels of radioactivity will be determined by Cerenkov counting. The amount of adducts will be calculated according to the procedures described previously (Reddy & Randerath, 1989) .
Results Task 2:
" 32 P Post Labeling analysis revealed that oxidation reaction in the presence of mitoplast and DES produced three major DNA adducts. These adducts had a similar migration pattern as the dGMP reacted with DES quinone. Based on chromatographic mobility we believe that the adducts produced by the mitochondrial oxidation system are dGMP adducts. Furthermore, DNA adducts were produced in the oxidation system containing DAS. (figure 5) However, the total amount of DNA adducts produced in the DAS containing reactions were decreased by 89% compared to the reactions containing no DAS. (Table 3) . No DNA adducts were produced in reactions without cumen hyudroperoxide (oxidation cofactor). (Data not shown) Therefore we conclude that DAS inhibits the formation of DES induced mitochondrial DNA adducts in vitro. We expect similar results in the microsomal and nuclear reactions. These reactions have not been preformed as of now.
Statement of Work (Task 3) :
To determine the in vivo formation of DNA adducts produced by DES and its inhibition by DAS.
1. Five groups of five animals will be used in this study. There will be one control, one group dosed with DES alone, and three groups dosed with DES and three different concentrations of DAS. 2. The animals will dosed with DAS one hour before DES. 3. The animals will be sacrificed four hours after DES exposure. 4. DNA from the mitochondria and nucleus will be analyzed by 32 p-Postlabeling for DNA adduct formation.
Progress for Task 3:
In vivo: Five groups of ten rats each was dosed with various concentrations of DES and DAS. The treatments are as follows: Group 1(Control) will receive corn oil only by i.p. injection. Group 2 will receive DES (150mg/kg, i.p.); Group 3 will receive DES (150mg/kg i.p.) and + DAS (25mg/kg p.o.); Group 4 will receive DES (150mg/kg, i.p) and .DAS (50mg/kg p.o.); Group 5 will receive DES (150mg/kg, i.p) and. DAS 100mg/kg p.o.). Both mtDNA and nDNA from breast tissue will be isolated from each group and analyzed by 32 p-postlabeling.
Results for task 3:
32 p Post Labeling analysis revealed that DES treatment of 150mg/kg produced two mitochondrial DNA adducts. These adducts were not seen in the control treated rats. ( figure 6 ). Further more no adducts were found in any of the DAS treated rats. We conclude the DAS inhibits the formation of DES induced DNA adducts in the breast tissue in vivo. This inhibition is speculated to occur by augmenting the regulation of metabolic enzymes and well as direct metabolic inhibition.
demonstrating that these organelles can metabolize DES to reactive intermediates, we have demonstrated that diallyl sulfide inhibits this metabolism in a noncompetitive fashion in all three organelles. This inhibition may help explain the mechanism of the chemopreventive actions of diallyl sulfide. Furthermore, we have shown that DAS inhibits the formation of mitochondrial DNA adducts in both in vitro and in vivo. This demonstrates that the direct inhibition of DES metabolism plays a role in the inhibition of DNA adduct formation. We have also shown that DAS administered several days prior to DES, inhibits the formation of DES induced DNA adducts. This implies that some process other than the direct inhibition of metabolism is involved in the inhibition of DES induced DNA adducts. We propose that the expression of CYP450 and Glutathione-S-transferase may be augmented by DAS to afford protection from the production of DES induced genotoxicity. The results of this study will help elucidate the mechanism of estrogen induced breast cancer. This data will provide a foundation for the further investigation of the chemopreventive properties of DAS and structurally similar compounds. 
